| Company/Division name | Aegis Life, Inc. |
| Parent company | Entos Pharmaceuticals |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2020 |
| Domestically, the work will be done: | Both |
| Country(ies) from which reshored: | Canada |
| City reshored to: | San Diego |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | novel DNA vaccines, Covid-19 vaccine, vaccines |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Skilled workforce availability/training, Other, Covid-19 |
